Used Visx Star S4 IR for Sale in Texas
Houston and Dallas LASIK centers run Visx Star S4 IR for precise refractive surgery with iris registration technology. Baseline pricing: $40,000–$80,000.
Texas prices run at national baseline: $40,000–$80,000.
Visx Star S4 IR - Key specifications
- Excimer laser
- LASIK/PRK
- iris registration
Pricing in Texas
Visx Star S4 IR vs alternatives
| Model | Brand | Used Price | Key Spec |
|---|---|---|---|
| Visx Star S4 IR ✓ | Abbott | $40,000–$80,000 | Excimer laser, LASIK/PRK, iris registration... |
| WaveLight EX500 | Alcon | $80,000–$160,000 | Excimer laser, LASIK, 500 Hz... |
| MEL 90 | Zeiss | $70,000–$140,000 | Excimer laser, LASIK/PRK, 250 Hz... |
| Allegretto Wave Eye-Q | Alcon | $50,000–$100,000 | Excimer, wavefront-optimized... |
Active buyers in Texas
Facilities in Texas currently using or sourcing Visx Star S4 IR:
- MD Anderson Cancer Center, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Baylor St. Luke's Medical Center, Houston
- UT Southwestern Medical Center, Dallas
- Parkland Memorial Hospital, Dallas
Clinical experts on Visx Star S4 IR
- Dr. Eric Donnenfeld - Ophthalmic Consultants of Long Island. 500+ publications, FDA investigator for VISX and Alcon LASIK platforms.
- Dr. Majid Moshirfar - University of Utah, Salt Lake City. 200+ publications on refractive surgery outcomes.
FAQ - Visx Star S4 IR in Texas
Is Visx Star S4 IR a good value alternative to newer excimer lasers for Texas practices?
Yes - it delivers established, well-documented refractive surgery capability at a lower acquisition cost than the newest premium platforms.
What is the price of used Visx Star S4 IR in Texas?
Texas prices run at national baseline: $40,000–$80,000. Price depends on hours, condition grade, and included accessories.
Does TechCosmetic ship Visx Star S4 IR to Texas?
Yes. We ship to all 50 states including Texas. Freight quotes within 24 hours, coordinated with local riggers in major Texas cities.
More on Visx Star S4 IR
Similar equipment
Zero buyer commission · 2-hour response